This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lommatzsch, M. Articles by Renz, H. Search for Related Content PubMed PubMed Citation Articles by Lommatzsch, M. Articles by Renz, H.

(American Journal of Pathology. 1999;155:1183-1193.)
© 1999 American Society for Investigative Pathology

Regular Articles

Abundant Production of Brain-Derived Neurotrophic Factor by Adult Visceral Epithelia

Implications for Paracrine and Target-Derived NeurotrophicFunctions

Marek Lommatzsch^*, Armin Braun^*, Anne Mannsfeldt, Vladimir A. Botchkarev, Natalia V. Botchkareva, Ralf Paus^¶, Axel Fischer^§, Gary R. Lewin and Harald Renz^*

From the Departments of Laboratory Medicine and Pathobiochemistry ^*
and Dermatology,
Charité, Humboldt University, Berlin; the Growth Factor and Regeneration Group,
Max Delbrück Centrum (MDC) for Molecular Medicine, Berlin; and the Department of Anatomy and Cell Biology,^§
Justus Liebig University, Giessen, Germany; and the Department of Dermatology,^¶
University Hospital, Eppendorf University, Hamburg, Germany

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Brain-derived neurotrophic factor (BDNF) plays a crucial role for the survival of visceral sensory neurons during development. However, the physiological sources and the function of BDNF in the adult viscera are poorly described. We have investigated the cellular sources and the potential role of BDNF in adult murine viscera. We found markedly different amounts of BDNF protein in different organs. Surprisingly, BDNF levels in the urinary bladder, lung, and colon were higher than those found in the brain or skin. In situ hybridization experiments revealed that BDNF mRNA was made by visceral epithelial cells, several types of smooth muscle, and neurons of the myenteric plexus. Epithelia that expressed BDNF lacked both the high- and low-affinity receptors for BDNF, trkB and p75^NTR. In contrast, both receptors were present on neurons of the peripheral nervous system. Studies with BDNF-/-mice demonstrated that epithelial and smooth muscle cells developed normally in the absence of BDNF. These data provide evidence that visceral epithelia are a major source, but not a target, of BDNF in the adult viscera. The abundance of BDNF protein in certain internal organs suggests that this neurotrophin may regulate the function of adult visceral sensory and motor neurons.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

Though there is good evidence for the fundamental role of target-derived BDNF for the development of visceral innervation,^13,14 the role of target-derived BDNF for adult visceral neurons is rather unknown. Recently, it has been observed that inflammatory diseases of the adult viscera are associated with a strong increase in local BDNF mRNA and protein production.^15-17 These observations raised the possibility that BDNF might mediate changes in neuronal function in pathological conditions, in that there is growing evidence for a functional role for BDNF in the normal adult peripheral nervous system.^18-21 The involvement of target-derived mechanisms has been suggested, because there is recent evidence for retrograde transport of BDNF in adult visceroafferent and visceroefferent neurons.²² This is supported by the finding that there are many more neurons in the adult nodose and petrosal ganglion (NPG) and (DRG) that contain BDNF protein than produce BDNF mRNA.^23,24 Though target-derived actions of BDNF in the adult viscera have been discussed, a systematic study of BDNF expression in the viscera is still lacking. Moreover, most reports do not identify the cellular sources of BDNF. There is some evidence for the presence of BDNF mRNA in extracts from the lung, heart, and spleen^25-27 and of BDNF protein in extracts of the rat liver and thymus.²⁸ As possible physiological sources of BDNF, only fibroblasts,^29-31 vascular smooth muscle cells,^32,33 and thymic stroma cells have been identified so far.³⁴

It was the aim of this study, therefore, to investigate systematically the expression and potential role of BDNF in the targets of adult visceral sensory and motor neurons. Using a nonradioactive in situ hybridization technique, which gives very good cellular resolution, we identified the cells synthesizing BDNF mRNA in all gastrointestinal regions and in tissues of the cardiorespiratory and urogenital systems. In addition, we quantified the amounts of BDNF protein present in these internal organs. Furthermore, we have examined the distribution of BDNF receptors and the morphology of viscera in mice lacking BDNF. We found that BDNF is expressed in certain viscera in even higher amounts than in the brain. The distribution of BDNF receptors and the phenotype of BDNF-/- mice suggest a primarily neurotrophic role for BDNF made by visceral epithelia. We conclude that visceral BDNF could indeed regulate functional properties of adult PNS neurons.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Animals

Female Balb/c mice were obtained from Harlan-Winkelmann (Borchen, Germany). FVB/N transgenics were genotyped by polymerase chain reaction (PCR) analysis as described before.^35,36 Wild-type and BDNF-/- mice were obtained from the mating of BDNF+/- mice maintained at the Max Delbrück Centrum, Berlin. The production and maintenance of these mice have been described elsewhere.²¹ Paraffin sections (2 µm) of internal organs from 2-week-old wild-type (+/+) and BDNF-/- mice were stained with hematoxylin-eosin (HE) following standard laboratory procedures.

In Situ Hybridization (ISH)

The riboprobe for BDNF was prepared as described by Schaeren-Wiemers and Gerfin-Moser.³⁷ Briefly, for in vitro transcription 1 µg of linearized plasmid containing 510 bp of the BDNF coding sequence (nucleotides 224–734) was used as a template.³⁸ The reaction was performed in a 50-µl volume using the DIG-RNA-labeling mix from Boehringer Mannheim (Mannheim, Germany) and a T7 (anti-sense) or T3 (sense control) polymerase (Promega, Madison, WI). After a 3-hour incubation the reaction was stopped by adding DNase. The probe was hydrolyzed by adding two volumes of carbonate buffer (60 mmol/L Na₂CO₃, 40 mmol/L NaHCO₃, pH 10.2) followed by 45 minutes' incubation at 60°C. After neutralization with an equal volume of neutralization buffer (200 mmol/L Na-acetate, 1% acetic acid, pH 6.0), the probe was purified by ethanol precipitation. To estimate the concentration of the probe a dot blot was performed as recommended by the manufacturer (Boehringer Mannheim) for nonradioactive ISH. Probes were stored at -80°C.

Organs from 8-week-old Balb/c mice were immediately frozen in Tissue Tek (Miles, Elkhart, IN). Slides were coated with 2% APES (3-Aminopropyltriethoxysilane, Sigma, Deisenhofen, Germany) in Aceton under RNase-free conditions. Ten-micron cryosections were dried for 30 minutes, fixed in 4% cold paraformaldehyde for 10 minutes, and then washed in RNase-free PBS. Two sequential sections of each organ were used for anti-sense and sense staining. After acetylation, sections were washed in PBS. For prehybridization, 500 µl of hybridization buffer (50% formamide, 4x SSC, 2x Denhardt's solution, 50 µg/ml RNA-core from baker's yeast) were added to each slide. The slides were placed in a humid chamber containing a 50% formamide/4x SSC mix at the bottom. The hybridization mixture was prepared by adding 150 ng/ml digoxigenin (DIG)-labeled cRNA (anti-sense or sense) to the hybridization buffer. To denature the probe the mixture was incubated at 85°C for 5 minutes. The prehybridization solution was allowed to drip off the slides, and 200 µl of hybridization mixture were added to each slide. Hybridization was performed overnight at 56°C. Posthybridization washes were carried out in the following sequence: 4x 10 minutes in 2x SSC at 67°C, 45 minutes in 2x SSC at 67°C, 60 minutes in 0.1x SSC at 67°C, 10 minutes in 0.2x SSC at room temperature. Detection of the DIG-labeled probe was performed as described in the manufacturer's instructions, with antibody incubation overnight at 4°C. Color development was allowed to proceed in the dark for 2 hours. The reaction was terminated by immersing the slides in PBS, pH 7.5.

Preparation of Tissue Lysates

Organs from 8-week-old Balb/c mice were prepared and pulverized in liquid nitrogen. The lysing buffer contained 50 mmol/L Tris, pH 8.0, 150 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L phenylmethylsulfonylfluoride, 5 mmol/L Iodacetamid, 10 mg/ml aprotinin, and (as detergents) 0.2% SDS, 1% Triton X-100, and 1% Igepal (Sigma). Protein extraction was performed as described before.³⁹ The lysing solutions were centrifuged at 2000 x g, 4°C, for 30 minutes and supernatants stored at -80°C. Total protein content was measured using the detergent-compatible BCA protein assay (Pierce, Rockford, IL).

Determination of BDNF Protein by Enzyme-Linked Immunosorbent Assay (ELISA)

BDNF in lysates was measured using commercial ELISA kits according to the manufacturer's instructions (Promega) as described.¹⁷ The detection limit was 4 pg/ml. Measurements were performed in duplicate. Concentrations of BDNF were calculated as nanograms of BDNF per gram of total protein.

trkB and p75^NTR Immunoreactivity

Immunoreactivity against the full-length form of mouse trkB (gp 145) was studied on acetone-fixed cryosections (10 µm) of 8-week-old Balb/c mice internal organs using rabbit antisera (Transduction Laboratories, Lexington, KY) and TRITC-conjugated goat anti-rabbit IgG as the secondary antibody, as described before.^40,41 Sections were counterstained by Hoechst 33342 (Sigma, St. Louis, MO; 10 mg/ml in TBS, 30 minutes) for identification of cell nuclei as described.⁴² For detection of p75^NTR immunoreactivity, APAAP-staining was performed as described elsewhere,⁴³ using a monoclonal rat anti-mouse p75^NTR primary antibody (Chemicon, Temecula, CA). Sections were counterstained with haemalaun. Incubation of internal organ cryosections without primary antibody was used as a negative control in both experiments. Slides were studied using a fluorescence Zeiss Axioscope microscope and photodocumented using a digital image analysis system (ISIS Metasystem, Altlussheim, Germany).

Specificity Control

The heart of BDNF-overexpressing mice (FVB/N, alpha-myosin heavy-chain promoter³⁶ ) and BDNF-/- knockout mice served as a positive and negative control for ELISA and ISH. Transgenic heart lysates showed 20-fold higher concentrations of BDNF (583.3 ± 151.8 ng BDNF/g total protein) than FVB/N wild-type heart lysates (30.5 ± 3.7 ng/g), whereas BDNF was not detectable in heart lysates of BDNF knockouts. ISH revealed a strong and ubiquitous BDNF mRNA staining in cardiomyocytes of BDNF overexpressors. Wild-type hearts displayed distinct BDNF mRNA-positive cardiomyocytes, BDNF-/- hearts were completely BDNF mRNA-negative (not shown). BDNF levels in back skin lysates (telogen) of Balb/c mice ranged at 8.5 ± 2.1 ng/g (Figure 1A) , concentrations of BDNF in total brain lysates at 5.9 ± 1.5 ng/g, according to reported data.³⁸

View larger version (16K): [in this window] [in a new window]   Figure 1. BDNF protein concentrations in internal organ lysates. BDNF protein concentrations in total organ lysates of 8-week-old Balb/c mice were measured by ELISA and calculated as nanograms of BDNF per gram of total protein. Shown are the means with each standard deviation (n = 4). A: BDNF protein in the total brain, back skin and cardiorespiratory system. B: BDNF protein in the gastrointestinal tract. C: BDNF protein in the urogenital tract.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

In the gastrointestinal tract, the BDNF protein content differed markedly between organs (Figure 1B) . High concentrations of BDNF were detected in the colon and duodenum, low concentrations in the ileum. In the liver and pancreas, BDNF levels were comparable to those measured in the total brain (Figure 1A) . In contrast, the submandibular gland contained very low concentrations of BDNF. In order to identify the cellular sources of BDNF, mRNA expression was examined with nonradioactive ISH (Table 1) . The internal circular muscle layer of the tunica muscularis was BDNF mRNA positive throughout the intestine. In contrast, the outer longitudinal muscle layer remained negative (Figure 2 , colon). An exception was the upper esophagus, where distinct muscle fibers of the outer layer appeared positive (Figure 3 , esophagus). BDNF expression was detected in epithelia throughout the intestinal tract (Table 1) . Intense signals were observed on the bottom of the crypts or of gastric foveolae, respectively. Expression levels appeared to be lower toward the apical cell layers (Figure 2 , colon and stomach). Prominent BDNF expression was observed in epithelia of the colon (Figure 2 , colon), in contrast, only weak expression was seen in the ileum. Ganglia of the myenteric plexus were BDNF mRNA positive throughout the intestine (arrow in Figure 2 , colon). BDNF mRNA was detectable in the peritoneal cell layer of the intestine as on other internal organs (Figure 3 , peritoneum). In the liver, hepatocytes were identified as the main sources of BDNF mRNA (Figure 2 , liver). Epithelia of exocrine ducts remained unstained in all examined glands (Table 1) .

View larger version (123K): [in this window] [in a new window]   Figure 2. BDNF expression in internal organs. Detection of BDNF mRNA was performed on 10-µm cryosections by ISH. Sequential sections were hybridized with anti-sense or sense riboprobes, respectively. Shown are the cortex of the kidney, a liver lobe with central vein, mucosa and tunica muscularis of the stomach, and sigmoid colon. Note the BDNF mRNA negative glomerula in the kidney. The arrow in the micrograph of the colon shows a BDNF mRNA-positive ganglion of the myenteric plexus. Scale bar, 27 µm. L, lumen; CV, central vein; G, glomerulum; SM, smooth muscle; BM, basal membrane and submucosa of the stomach.

View larger version (78K): [in this window] [in a new window]   Figure 3. BDNF expression in visceral epithelia. Sequential cryosections were hybridized with anti-sense and sense riboprobes. The first slide of each set was stained with hematoxylineosine (HE). Shown are the mucosa and tunica muscularis of the upper part of esophagus, of a medium-sized bronchus in the lung, of the urinary bladder, the squamous epithelium on the portio vaginalis uteri, mucosa and submucosa of the oviduct, and the peritoneal serosa layer on the myometrium muscle. Arrows indicate the basal membrane of the epithelia. Note that also adjacent stroma cells in the oviduct appear BDNF mRNA-positive. On the negative myometrium background, peritoneal BDNF mRNA signals are easily to identify by blue staining in the peritoneum. Scale bar, 13.5 µm. L, lumen; A, airway; C, peritoneal cavity.

A striking pattern of BDNF mRNA-expressing cells was observed in the lung. Respiratory epithelium was strongly BDNF mRNA positive from trachea up to the bronchioli. Airway smooth muscle cells as well as smooth muscle cells of pulmonary vessels (Table 1) were moderately positive (Figure 3 , lung). This expression pattern was mirrored in the very high BDNF content measured in lysates taken from lung (Figure 1A) . The BDNF protein contents found in the heart were significantly lower than those found in the lung. ISH showed that only a few cardiomyocytes were BDNF mRNA-positive (Table 1) .

Urogenital Tract

BDNF protein levels in the kidney were comparable to those found in the brain. In contrast, lysates taken from the urinary bladder revealed a much higher concentration of BDNF (Figure 1C) . BDNF protein was also detectable in the urine (24.98 ± 14.78 pg/ml), though serum levels were below the detection limit (<4 pg/ml). BDNF protein levels in the oviduct were significantly higher than in the uterus (Figure 1C) . For the identification of cellular BDNF expression, BDNF mRNA was detected by ISH. Proximal and distal tubules of the kidney displayed strong BDNF expression. No expression was observed in glomerula (Figure 2 , kidney). Renal vascular smooth muscle cells appeared to be BDNF mRNA negative (not shown). Urothelia of the urinary bladder revealed very strong BDNF expression. In contrast, the tunica muscularis was BDNF mRNA-negative (Figure 3 , bladder). BDNF mRNA was found in epithelia of the uterus and oviduct. There was also a light expression in adjacent cells of the lamina propria (Figure 3 , tuba uterina). Interestingly, BDNF mRNA was not detectable in the squamous epithelium of the portio vaginalis uteri (Figure 3 , cervix uteri).

trkB and p75^NTR Immunoreactivity (IR)

The strong BDNF expression in visceral epithelia raised the question whether BDNF could also play an autocrine role for non-neuronal structures in the adult viscera. However, almost all epithelia in the examined internal organs were both trkB-IR and p75^NTR-IR-negative (Table 1) . Arrowheads in Figure 4 (colon) show epithelial structures of the transverse colon, which are negative for trkB-IR and p75^NTR-IR. An exception was the squamous epithelium of the portio vaginalis uteri, which was trkB-IR-positive (red fluorescence), but p75^NTR-IR-negative (arrowheads in Figure 4 , cervix uteri). Most smooth muscle layers appeared to possess neither trkB nor p75^NTR receptors (Figure 4 , colon). However, prominent p75^NTR-IR was detected in the tunica muscularis of the oviduct and in the myometrium (Table 1) . Strongest p75^NTR-IR was revealed in the lamina propria underneath the epithelia of the uterus and oviduct, probably representing connective tissue cells. Figure 4 , cervix uteri, shows p75^NTR-IR (red staining) underneath the squamous epithelium of the portio vaginalis uteri. Scattered trkB-IR was detectable in muscle fibers of the upper esophagus (Table 1) . Neurons and nerve fibers of the myenteric plexus showed trkB-IR as well as p75^NTR-IR (Table 1) . White arrows in Figure 4 , Colon show trkB-IR (red fluorescence), black arrows p75^NTR-IR (red staining) on myenteric neurons and nerve fibers of the colon.

View larger version (101K): [in this window] [in a new window]   Figure 4. BDNF receptors in the colon and cervix uteri. Immunohistochemistry was performed against the full-length trkB and p75NTR receptors on 10-µm cryosections of Balb/c mice internal organs. Sections were counterstained by Hoechst 33342 (blue fluorescence) for identification of cell nuclei (trkB) or by haemalaun (p75NTR). Incubation of inner organ cryosections without primary antibody served as a negative control (not shown). trkB (red fluorescence) or p75NTR staining (red APAAP staining) was evaluated in comparison to this background. Shown are sections of the portio vaginalis uteri and transverse colon. Arrowheads in all figures indicate epithelia, arrows in the micrograph of colon neurons and nerve fibers of the myenteric plexus. Scale bar, 50 µm.

To further analyze the role of BDNF for non-neuronal structures of the viscera, we examined the viscera of mice lacking BDNF. The morphology of internal organs of 2-week-old wild-type (n = 4) and BDNF-/- mice (n = 4) was examined using HE-stained 2-µm paraffin sections. Throughout the gastrointestinal tract, the intestinal mucosa was present and displayed no gross morphological changes. However, the whole intestine appeared markedly hypotrophic. The ileum and duodenum showed no reduction in mucosal thickness and a regular relation of crypts and villi. The colon displayed a mucosal atrophy. Goblet cells of the colon appeared enlarged, probably due to a retention of mucus. Figure 5 , colon shows the wall of a wild-type and a BDNF-/- transverse colon. The morphology of pancreatic and hepatic epithelia was unaltered; these organs appeared normal (not shown). Furthermore, the BDNF-/- lung and heart were indistinguishable from wild-type organs. Figure 5 , lung, shows the respiratory epithelium and airway smooth muscle of a main bronchus. Epithelial and smooth muscle structures in organs of the urogenital tract (kidney, uterus, oviduct, urinary bladder) appeared unaltered in thickness and morphology as well (not shown).

View larger version (131K): [in this window] [in a new window]   Figure 5. Epithelia of BDNF-/- mice. Two-micron paraffin sections of 2-week-old wild-type and BDNF-/- mice internal organs were HE-stained following standard laboratory procedures. Shown are sections of the transverse colon wall and respiratory epithelium and airway smooth muscle of a main bronchus of wild-type and BDNF-/- mice. Note the mucosal atrophy and enlarged goblet cells (GC) in the BDNF-/- colon. Lungs were indistinguishable between wild-type and BDNF-/- mice; the respiratory epithelium was unaltered in morphology and height. Scale bar, 13.5 µm. L, lumen; A, airway; GC, goblet cells; SM, smooth muscle.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

In the last few years, BDNF mRNA expression has been reported in various gustatory and olfactory sensory epithelia^46-48 and in epithelial cells of the cochlea and vestibulum.^49-52 These sensory epithelia represent innervation targets for neuronal populations, which were reported to be dependent on BDNF. Visceroafferent neurons of internal organs, which are mainly located in the nodose/petrosal ganglion (NPG) and dorsal root ganglia (DRG), were shown to require BDNF during development.^9,10 Recently, it has been shown that during normal development BDNF is transiently expressed at high levels in the targets of arterial baroreceptive and chemoreceptive sensory neurons that have their cell bodies in the NPG.¹³ This expression is coordinated with the arrival of sensory axons in these targets.¹³ In addition, the onset of trkB expression in neurons of the NPG has been shown to correlate with the onset of BDNF expression in peripheral targets of NPG neurons.^14,27 In the adult animal, retrograde transport of BDNF was recently demonstrated by neurons with their axons in the vagus nerve.²² A small number of these neurons had their cell bodies in the NPG, but many motoneurons with their cell bodies in the brainstem also retrogradely transported radiolabeled BDNF. Thus, although the presence of trkB-expressing NPG neurons in the adult animal has been disputed,^23,53 motoneurons innervating the viscera appear to be able to utilize endogenous target-derived BDNF.²² It is also not in dispute that many adult sensory neurons innervating the viscera with their cell bodies in the DRG possess trkB receptors.^23,45 The fact that more sensory neurons in the adult NPG and DRG contain BDNF protein than produce BDNF mRNA further support a role of retrogradely transported BDNF.^23,24,54 The possible function of target-derived BDNF in the adult animal is still relatively obscure, although evidence does exist that this factor can influence the functional properties of mature sensory and motoneurons.^21,55 It may still be the case that BDNF is required for the survival of adult neurons, but, as no conditional knockouts have yet been described, this issue is still open.

Information on BDNF's role in the ENS is very limited. Furthermore, there are conflicting data about trkB receptor expression in human and rat enteric plexuses.^56,57 The finding that BDNF receptors were identified only on neuronal structures of the gut suggest that the observed BDNF expression in epithelial and smooth muscle cells could influence predominantly innervating neurons. Because there are no data available about the role of BDNF in adult myenteric plexus neurons, both survival and nonsurvival functions are conceivable. The examined BDNF-/- mice did not feed properly, as described elsewhere.¹¹ Though there was some food in the stomach, the intestinal tract appeared nearly empty. Hence, the hypotrophy of the whole intestine in BDNF-/- mice is most likely due to malnutrition. The marked reduction of food intake is probably also the reason that the (completely empty) colon displayed a mucosal atrophy and significant mucus retention in goblet cells.

BDNF levels in the lung and urinary bladder were 5- to 15-fold higher than in total brain lysates and even higher than BDNF levels previously described in the hippocampus.⁵⁸ The levels of BDNF in the urinary bladder are, to some extent, consistent with the finding that nearly all adult afferents projecting through the pelvic nerve are trkB-positive.⁴⁵ However, the viscera is a relatively sparsely innervated region in comparison to other somatic tissues.⁵⁹ It is, therefore, surprising that the amount of BDNF message and protein expressed by certain viscera is so large compared to somatic tissues, eg, the densely innervated skin. BDNF has been described as playing a role in skin innervation.^21,60-62 BDNF protein levels in the skin, however, were significantly lower than in certain inner organs (8 ng/g in the back skin versus, e.g., 80 ng/g in the urinary bladder). It thus appears that, at least in adults, visceral BDNF may also play a role in the functional regulation of visceral motor and sensory as well as possibly enteric neurons.^18,63 There is recent evidence demonstrating that BDNF can regulate the capsaicin sensitivity of adult visceral sensory neurons²⁰ as well as several functional properties of adult motoneurons.^18,19 Furthermore, it has been well established that BDNF plays a nonsurvival role in CNS neurons.¹¹ Hippocampal neurons especially require BDNF for the expression of synaptic changes associated with long-term potentiation (LTP).^64,65 It is, therefore, conceivable that BDNF, in contrast to developmental stages, could act primarily on functional properties of PNS neurons.

Recent studies demonstrate that inflammatory diseases of the adult viscera are associated with a local up-regulation of BDNF mRNA and protein production. Interestingly, these observations focus on inner organs we found to be the predominant physiological sources of BDNF in adult viscera (lung and urinary bladder). Allergic asthmatic patients respond with a marked increase of BDNF levels during inflammation in the lung after allergen provocation.¹⁷ In a mouse model of allergic bronchial asthma, we demonstrated that this local increase is due at least in part to an up-regulation of BDNF mRNA production in infiltrating immune cells, including macrophages and T cells.¹⁵ The production of BDNF in activated human immune cells has been demonstrated recently.⁶⁶ In addition, a strong local up-regulation of BDNF mRNA was demonstrated in the inflamed urinary bladder.¹⁶ It is well established that the closely related nerve growth factor (NGF) contributes to the characteristic neuronal changes in allergic bronchial asthma and in cystitis. In animal models of these diseases, blocking of NGF partly prevented neuronal changes which follow inflammation.^43,67 Therefore, a similar functional role of locally produced BDNF has been suggested in inflammatory conditions. These observations indicate that BDNF could mediate functional neuronal changes in pathological conditions of the viscera, especially of the lung and urinary bladder.

An additional novel finding is the p75^NTR expression on smooth muscle cells of the myometrium. A major role of p75^NTR has been postulated recently in myogenic differentiation.^68,69 These studies showed that NGF is capable of stimulating myoblast proliferation and differentiation via p75^NTR. In addition, NGF and p75^NTR down-regulation was shown to be essential for the terminal myogenic differentiation. The observed p75^NTR-IR on the myometrium could, therefore, indicate the plasticity and growth potency of the uterine smooth muscle. Autocrine processes of BDNF seem not to be involved, because the myometrium was completely negative for BDNF mRNA. Paracrine actions of BDNF, however, have to be considered not only on uterine smooth muscle cells, but also on the squamous epithelium of the portio, because BDNF has been demonstrated recently to promote keratinocyte proliferation via trkB.⁷⁰

In summary, we have shown the extensive cellular BDNF expression in non-neuronal innervation targets of adult murine viscera. Non-neuronal tissues expressing BDNF did not display BDNF receptors and revealed no architectural changes in BDNF-/- mice. The surprisingly high concentrations of BDNF protein in certain internal organs suggest that this protein probably also regulates functional properties of adult PNS neurons innervating the viscera.

	Acknowledgements

 
We thank Gudrun Holland and Prof. Norbert Schnoy for the preparation of paraffin sections and Cornelia Radke, M.D., for substantial advice. We thank Margarita Strozynski, Christine Seib, Anke Kanehl, and Ruth Pliet for their excellent technical assistance and support.

	Footnotes

 
Address reprint requests to Harald Renz, M.D., Department of Laboratory Medicine and Pathobiochemistry, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail: harald.renz{at}charite.de

Supported by Volkswagen Stiftung.

This work is dedicated to the 60th birthday of Prof. Eckart Köttgen.

Accepted for publication June 30, 1999.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Lewin GR, Barde YA: Physiology of the neurotrophins. Annu Rev Neurosci 1996, 19:289-317[Medline]
2. Martin Zanca D, Hughes SH, Barbacid M: A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 1986, 319:743-748[Medline]
3. Barbacid M: The Trk family of neurotrophin receptors. J Neurobiol 1994, 25:1386-1403[Medline]
4. Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA: Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989, 341:149-152[Medline]
5. Kalcheim C, Barde YA, Thoenen H, Le Douarin NM: In vivo effect of brain-derived neurotrophic factor on the survival of developing dorsal root ganglion cells. EMBO J 1987, 6:2871-2873[Medline]
6. Davies AM, Thoenen H, Barde YA: The response of chick sensory neurons to brain-derived neurotrophic factor. J Neurosci 1986, 6:1897-1904[Abstract]
7. Lindsay RM, Thoenen H, Barde YA: Placode and neural crest-derived sensory neurons are responsive at early developmental stages to brain-derived neurotrophic factor. Dev Biol 1985, 112:319-328[Medline]
8. Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL, Barbacid M: Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 1993, 75:113-122[Medline]
9. Ernfors P, Lee KF, Jaenisch R: Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 1994, 368:147-150[Medline]
10. ElShamy WM, Ernfors P: Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 complement and cooperate with each other sequentially during visceral neuron development. J Neurosci 1997, 17:8667-8675[Abstract/Free Full Text]
11. Snider WD: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994, 77:627-638[Medline]
12. Erickson JT, Conover JC, Borday V, Champagnat J, Barbacid M, Yancopoulos G, Katz DM: Mice lacking brain-derived neurotrophic factor exhibit visceral sensory neuron losses distinct from mice lacking NT4 and display a severe developmental deficit in control of breathing. J Neurosci 1996, 16:5361-5371[Abstract/Free Full Text]
13. Brady R, Zaidi SI, Mayer C, Katz DM: BDNF is a target-derived survival factor for arterial baroreceptor and chemoafferent primary sensory neurons. J Neurosci 1999, 19:2131-2142[Abstract/Free Full Text]
14. Vogel KS, Davies AM: The duration of neurotrophic factor independence in early sensory neurons is matched to the time course of target field innervation. Neuron 1991, 7:819-830[Medline]
15. Braun A, Lommatzsch M, Mannsfeldt A, Neuhaus-Steinmetz U, Fischer A, Schnoy N, Lewin GR, Renz H: Cellular sources of enhanced brain-derived neurotrophic factor (BDNF) production in a mouse model of allergic inflammation. Am J Resp Cell Mol Biol 1999, in press.
16. Oddiah D, Anand P, McMahon SB, Rattray M: Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport 1998, 9:1455-1458[Medline]
17. Virchow JC, Julius P, Lommatzsch M, Luttmann W, Renz H, Braun A: Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 1998, 158:2002-2005[Abstract/Free Full Text]
18. Gonzalez M, Collins WF: Modulation of motoneuron excitability by brain-derived neurotrophic factor. J Neurophysiol 1997, 77:502-506[Abstract/Free Full Text]
19. Fernandes KJ, Kobayashi NR, Jasmin BJ, Tetzlaff W: Acetylcholinesterase gene expression in axotomized rat facial motoneurons is differentially regulated by neurotrophins: correlation with trkB and trkC mRNA levels and isoforms. J Neurosci 1998, 18:9936-9947[Abstract/Free Full Text]
20. Winter J: Brain derived neurotrophic factor, but not nerve growth factor, regulates capsaicin sensitivity of rat vagal ganglion neurones. Neurosci Lett 1998, 241:21-24[Medline]
21. Carroll P, Lewin GR, Koltzenburg M, Toyka KV, Thoenen H: A role of BDNF in mechanosensation. Nature Neurosci 1998, 1:42-46[Medline]
22. Helke CJ, Adryan KM, Fedorowicz J, Zhuo H, Park JS, Curtis R, Radley HE, Distefano PS: Axonal transport of neurotrophins by visceral afferent and efferent neurons of the vagus nerve of the rat. J Comp Neurol 1998, 393:102-117[Medline]
23. Wetmore C, Olson L: Neuronal and nonneuronal expression of neurotrophins and their receptors in sensory and sympathetic ganglia suggest new intercellular trophic interactions. J Comp Neurol 1995, 353:143-159[Medline]
24. Zhou XF, Chie ET, Rush RA: Distribution of brain-derived neurotrophic factor in cranial and spinal ganglia. Exp Neurol 1998, 149:237-242[Medline]
25. Rosenthal A, Goeddel DV, Nguyen T, Martin E, Burton LE, Shih A, Laramee GR, Wurm F, Mason A, Nikolics K, Winslon JW: Primary structure and biological activity of human brain-derived neurotrophic factor. Endocrinology 1991, 129:1289-1294[Abstract]
26. Yamamoto M, Sobue G, Yamamoto K, Terao S, Mitsuma T: Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues. Neurochem Res 1996, 21:929-938[Medline]
27. Robinson M, Adu J, Davies AM: Timing and regulation of trkB and BDNF mRNA expression in placode-derived sensory neurons and their targets. Eur J Neurosci 1996, 8:2399-2406[Medline]
28. Katoh Semba R, Takeuchi IK, Semba R, Kato K: Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J Neurochem 1997, 69:34-42[Medline]
29. Acheson A, Barker PA, Alderson RF, Miller FD, Murphy RA: Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: inhibition by antibodies to NGF. Neuron 1991, 7:265-275[Medline]
30. D'Mello S, Jiang C, Lamberti C, Martin SC, Heinrich G: Differential regulation of the nerve growth factor and brain-derived neurotrophic factor genes in L929 mouse fibroblasts. J Neurosci Res 1992, 33:519-526[Medline]
31. Cartwright M, Mikheev AM, Heinrich G: Expression of neurotrophin genes in human fibroblasts: differential regulation of the brain-derived neurotrophic factor gene. Int J Dev Neurosci 1994, 12:685-693[Medline]
32. Scarisbrick IA, Jones EG, Isackson PJ: Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. J Neurosci 1993, 13:875-893[Abstract]
33. Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tessarollo L, Mahadeo D, Sharif S, Kaplan DR, Tsoulfas P, Parada L: Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 1995, 147:309-324[Abstract]
34. Maroder M, Bellavia D, Meco D, Napolitano M, Stigliano A, Alesse E, Vacca A, Giannini G, Frati L, Gulino A, Screpanti I: Expression of trKB neurotrophin receptor during T cell development: role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol 1996, 157:2864-2872[Abstract]
35. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J: Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 1991, 266:24613-24620[Abstract/Free Full Text]
36. Subramaniam A, Birkenberger L, Ecker V, Kudlacz E, Krakowsky J, O'Connor T: Enhanced peripheral innervation in mice overexpressing brain-derived neurotrophic factor. Am J Resp Crit Care Med 1997, 155:A484
37. Schaeren Wiemers N, Gerfin Moser A: A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 1993, 100:431-440[Medline]
38. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA: Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 1990, 9:2459-2464[Medline]
39. Welker P, Foitzik K, Bulfone Paus S, Henz BM, Paus R: Hair cycle-dependent changes in the gene expression and protein content of transforming factor beta 1 and beta 3 in murine skin. Arch Dermatol Res 1997, 289:554-557[Medline]
40. Botchkarev VA, Eichmuller S, Johansson O, Paus R: Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol 1997, 386:379-395[Medline]
41. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA: Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992, 360:757-759[Medline]
42. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R: Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol 1997, 151:1601-1617[Abstract]
43. Braun A, Appel E, Baruch R, Herz U, Botchkarev V, Paus R, Brodie C, Renz H: Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998, 28:3240-3251[Medline]
44. Shibayama E, Koizumi H: Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am J Pathol 1996, 148:1807-1818[Abstract]
45. McMahon SB, Armanini MP, Ling LH, Phillips HS: Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 1994, 12:1161-1171[Medline]
46. Nosrat CA, Ebendal T, Olson L: Differential expression of brain-derived neurotrophic factor and neurotrophin 3 mRNA in lingual papillae and taste buds indicates roles in gustatory and somatosensory innervation. J Comp Neurol 1996, 376:587-602[Medline]
47. Zhang C, Brandemihl A, Lau D, Lawton A, Oakley B: BDNF is required for the normal development of taste neurons in vivo. Neuroreport 1997, 8:1013-1017[Medline]
48. Deckner ML, Frisen J, Verge VM, Hokfelt T, Risling M: Localization of neurotrophin receptors in olfactory epithelium and bulb. Neuroreport 1993, 5:301-304[Medline]
49. Ernfors P, Van De Water T, Loring J, Jaenisch R: Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 1995, 14:1153-1164[Medline]
50. Schecterson LC, Bothwell M: Neurotrophin and neurotrophin receptor mRNA expression in developing inner ear. Hear Res 1994, 73:92-100[Medline]
51. Vazquez E, Van de Water TR, Del Valle M, Vega JA, Staecker H, Giraldez F, Represa J: Pattern of trkB protein-like immunoreactivity in vivo and the in vitro effects of brain-derived neurotrophic factor (BDNF) on developing cochlear and vestibular neurons. Anat Embryol Berl 1994, 189:157-167[Medline]
52. Pirvola U, Arumae U, Moshnyakov M, Palgi J, Saarma M, Ylikoski J: Coordinated expression and function of neurotrophins and their receptors in the rat inner ear during target innervation. Hear Res 1994, 75:131-144[Medline]
53. Zhuo H, Helke CJ: Presence and localization of neurotrophin receptor tyrosine kinase (TrkA, TrkB, TrkC) mRNAs in visceral afferent neurons of the nodose and petrosal ganglia. Mol Brain Res 1996, 38:63-70[Medline]
54. Kashiba H, Ueda Y, Ueyama T, Nemoto K, Senba E: Relationship between BDNF- and trk-expressing neurones in rat dorsal root ganglion: an analysis by in situ hybridization. Neuroreport 1997, 8:1229-1234[Medline]
55. Mendell LM: Neurotrophins and sensory neurons: role in development, maintenance and injury: a thematic summary. Philos Trans R Soc Lond B Biol Sci 1996, 351:463-467[Medline]
56. Sternini C, Su D, Arakawa J, de Giorgio R, Rickman DW, Davis BM, Albers KM, Brecha NC: Cellular localization of Pan-trk immunoreactivity and trkC mRNA in the enteric nervous system. J Comp Neurol 1996, 368:597-607[Medline]
57. Hoehner JC, Wester T, Pahlman S, Olsen L: Localization of neurotrophins and their high-affinity receptors during human enteric nervous system development. Gastroenterology 1996, 110:756-767[Medline]
58. Nawa H, Carnahan J, Gall C: BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. Eur J Neurosci 1995, 7:1527-1535[Medline]
59. Janig W: Neurobiology of visceral afferent neurons: neuroanatomy, functions, organ regulations and sensations. Biol Psychol 1996, 42:29-51[Medline]
60. Rice FL, Albers KM, Davis BM, Silos Santiago I, Wilkinson GA, LeMaster AM, Ernfors P, Smeyne RJ, Aldskogius H, Phillips HS, Barbacid M, DeChiara TM, Yancopoulos GD, Dunne CE, Fundin BT: Differential dependency of unmyelinated and A delta epidermal and upper dermal innervation on neurotrophins, trk receptors, and p75LNGFR. Dev Biol 1998, 198:57-81[Medline]
61. Fundin BT, Silos Santiago I, Ernfors P, Fagan AM, Aldskogius H, DeChiara TM, Phillips HS, Barbacid M, Yancopoulos GD, Rice FL: Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR. Dev Biol 1997, 190:94-116[Medline]
62. Botchkarev VA, Botchkareva NV, Lommatzsch M, Peters EMJ, Lewin GR, Subramaniam A, Braun A, Renz H, Paus R: BDNF overexpression induces differential increases among subsets of sympathetic innervation in murine back skin. Eur J Neurosci 1998, 10:3276-3283[Medline]
63. Arenas E, Akerud P, Wong V, Boylan C, Persson H, Lindsay RM, Altar CA: Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo. Eur J Neurosci 1996, 8:1707-1717[Medline]
64. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T: Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1995, 92:8856-8860[Abstract/Free Full Text]
65. Kang H, Schuman EM: Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995, 267:1658-1662[Abstract/Free Full Text]
66. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R: Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 1999, 189:865-870[Abstract/Free Full Text]
67. Dmitrieva N, Shelton D, Rice AS, McMahon SB: The role of nerve growth factor in a model of visceral inflammation. Neuroscience 1997, 78:449-459[Medline]
68. Seidl K, Erck C, Buchberger A: Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J Cell Physiol 1998, 176:10-21[Medline]
69. Erck C, Meisinger C, Grothe C, Seidl K: Regulation of nerve growth factor and its low-affinity receptor (p75NTR) during myogenic differentiation. J Cell Physiol 1998, 176:22-31[Medline]
70. Botchkarev VA, Metz M, Botchkareva NV, Welker P, Lommatzsch M, Renz H, Paus R: Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 act as "epitheliotrophins" in murine skin. Lab Invest 1999, 79:557-572[Medline]

This article has been cited by other articles:

				B. Bariohay, C. Tardivel, J. Pio, A. Jean, and B. Felix BDNF-TrkB signaling interacts with the GABAergic system to inhibit rhythmic swallowing in the rat Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1050 - R1059. [Abstract] [Full Text] [PDF]

				W Boesmans, P Gomes, J Janssens, J Tack, and P V. Berghe Brain-derived neurotrophic factor amplifies neurotransmitter responses and promotes synaptic communication in the enteric nervous system Gut, March 1, 2008; 57(3): 314 - 322. [Abstract] [Full Text] [PDF]

				S. Begliuomini, E. Casarosa, N. Pluchino, E. Lenzi, M. Centofanti, L. Freschi, M. Pieri, A.D. Genazzani, S. Luisi, and A. R. Genazzani Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor Hum. Reprod., April 1, 2007; 22(4): 995 - 1002. [Abstract] [Full Text] [PDF]

				B. Bariohay, B. Lebrun, E. Moyse, and A. Jean Brain-Derived Neurotrophic Factor Plays a Role as an Anorexigenic Factor in the Dorsal Vagal Complex Endocrinology, December 1, 2005; 146(12): 5612 - 5620. [Abstract] [Full Text] [PDF]

				R Staats, P Stoll, D Zingler, J C Virchow, and M Lommatzsch Regulation of brain-derived neurotrophic factor (BDNF) during sleep apnoea treatment Thorax, August 1, 2005; 60(8): 688 - 692. [Abstract] [Full Text] [PDF]

				Q. Yao, M. A. Haxhiu, S. I. Zaidi, S. Liu, A. Jafri, and R. J. Martin Hyperoxia enhances brain-derived neurotrophic factor and tyrosine kinase B receptor expression in peribronchial smooth muscle of neonatal rats Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L307 - L314. [Abstract] [Full Text] [PDF]

				M. Lommatzsch, K. Schloetcke, J. Klotz, K. Schuhbaeck, D. Zingler, C. Zingler, O. Schulte-Herbruggen, H. Gill, P. Schuff-Werner, and J. C. Virchow Brain-derived Neurotrophic Factor in Platelets and Airflow Limitation in Asthma Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 115 - 120. [Abstract] [Full Text] [PDF]

				C. D. Nandini, T. Mikami, M. Ohta, N. Itoh, F. Akiyama-Nambu, and K. Sugahara Structural and Functional Characterization of Oversulfated Chondroitin Sulfate/Dermatan Sulfate Hybrid Chains from the Notochord of Hagfish: NEURITOGENIC AND BINDING ACTIVITIES FOR GROWTH FACTORS AND NEUROTROPHIC FACTORS J. Biol. Chem., December 3, 2004; 279(49): 50799 - 50809. [Abstract] [Full Text] [PDF]

				M. Lommatzsch, J. Klotz, J. C. Virchow Jr., J. F. Watchko, B. S. Brozanski, P. V. Gordon, T. F. Yeh, H. C. Lin, C. C. Huang, and A. H. Jobe Postnatal Dexamethasone for Lung Disease of Prematurity N. Engl. J. Med., June 24, 2004; 350(26): 2715 - 2718. [Full Text] [PDF]

				E. A. Fox and M. S. Byerly A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R994 - R1004. [Abstract] [Full Text] [PDF]

				A. Ricci, L. Felici, S. Mariotta, F. Mannino, G. Schmid, C. Terzano, G. Cardillo, F. Amenta, and E. Bronzetti Neurotrophin and Neurotrophin Receptor Protein Expression in the Human Lung Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 12 - 19. [Abstract] [Full Text] [PDF]

				C. Nassenstein, A. Braun, V. J. Erpenbeck, M. Lommatzsch, S. Schmidt, N. Krug, W. Luttmann, H. Renz, and J. C. Virchow Jr. The Neurotrophins Nerve Growth Factor, Brain-derived Neurotrophic Factor, Neurotrophin-3, and Neurotrophin-4 Are Survival and Activation Factors for Eosinophils in Patients with Allergic Bronchial Asthma J. Exp. Med., August 4, 2003; 198(3): 455 - 467. [Abstract] [Full Text] [PDF]

				E. A. Fox, R. J. Phillips, E. A. Baronowsky, M. S. Byerly, S. Jones, and T. L. Powley Neurotrophin-4 Deficient Mice Have a Loss of Vagal Intraganglionic Mechanoreceptors from the Small Intestine and a Disruption of Short-Term Satiety J. Neurosci., November 1, 2001; 21(21): 8602 - 8615. [Abstract] [Full Text] [PDF]

				E. Parrott, M. Butterworth, A. Green, I. N. H. White, and P. Greaves Adenomyosis--A Result of Disordered Stromal Differentiation Am. J. Pathol., August 1, 2001; 159(2): 623 - 630. [Abstract] [Full Text]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal